Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AC Immune
Biotech
Roche’s Genentech returns Alzheimer’s assets to AC Immune
Genentech is walking away from an 18-year relationship by handing back rights to a pair of Alzheimer’s assets after suffering setbacks in the clinic.
Nick Paul Taylor
Jan 22, 2024 8:47am
Pfizer exec out the door—Chutes & Ladders
Jul 28, 2023 9:30am
Early data from AC Immune Alzheimer's vaccine suggest response
Jan 26, 2023 11:13am
Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step
Nov 30, 2022 10:40am
Where are they now? Tracking down 2012's Fierce 15
Aug 29, 2022 3:00am
Genentech, AC Immune reveal more about crenezumab failure
Aug 2, 2022 11:00am